{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:11:43Z","timestamp":1783041103885,"version":"3.54.6"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s40620-014-0149-x","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T07:41:20Z","timestamp":1418110880000},"page":"361-367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Consequences of hemolytic uremic syndrome among hemodialysis patients"],"prefix":"10.1093","volume":"28","author":[{"given":"Steven M.","family":"Brunelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Claxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel A.","family":"Anum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"key":"149_CR1","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.lpm.2011.10.028","volume":"41","author":"M Malina","year":"2012","unstructured":"Malina M, Roumenina LT, Seeman T, Le Quintrec M, Dragon-Durey MA, Schaefer F, Fremeaux-Bacchi V (2012) Genetics of hemolytic uremic syndromes. Presse Med 41:e105\u2013e114","journal-title":"Presse Med"},{"key":"149_CR2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5527\/wjn.v2.i3.56","volume":"2","author":"M Salvadori","year":"2013","unstructured":"Salvadori M, Bertoni E (2013) Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations. World J Nephrol 2:56\u201376","journal-title":"World J Nephrol"},{"key":"149_CR3","unstructured":"National Library of Medicine: atypical hemolytic-uremic syndrome. http:\/\/ghr.nlm.nih.gov\/condition\/atypical-hemolytic-uremic-syndrome . Accessed 18 March 2014"},{"key":"149_CR4","doi-asserted-by":"crossref","first-page":"908407","DOI":"10.4061\/2011\/908407","volume":"2011","author":"O Boyer","year":"2011","unstructured":"Boyer O, Niaudet P (2011) Hemolytic uremic syndrome: new developments in pathogenesis and treatment. Int J Nephrol 2011:908407","journal-title":"Int J Nephrol"},{"key":"149_CR5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","volume":"43","author":"AR Constantinescu","year":"2004","unstructured":"Constantinescu AR, Bitzan M, Weiss LS, Christen E, Kaplan BS, Cnaan A, Trachtman H (2004) Non-enteropathic hemolytic uremic syndrome: causes and short-term course. Am J Kidney Dis 43:976\u2013982","journal-title":"Am J Kidney Dis"},{"key":"149_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1542\/pir.22-11-365","volume":"22","author":"JJ Corrigan Jr","year":"2001","unstructured":"Corrigan JJ Jr, Boineau FG (2001) Hemolytic-uremic syndrome. Pediatr Rev 22:365\u2013369","journal-title":"Pediatr Rev"},{"key":"149_CR7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","volume":"6","author":"C Loirat","year":"2011","unstructured":"Loirat C, Fremeaux-Bacchi V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6:60","journal-title":"Orphanet J Rare Dis"},{"key":"149_CR8","first-page":"27","volume":"33","author":"JM Campistol","year":"2013","unstructured":"Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa M, Grinyo JM, Praga M, Torra R, Vilalta R, Rodriguez de Cordoba S (2013) An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia 33:27\u201345","journal-title":"Nefrologia"},{"key":"149_CR9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","volume":"8","author":"J Zuber","year":"2012","unstructured":"Zuber J, Fakhouri F, Roumenina LT, Loirat C, Fremeaux-Bacchi V (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8:643\u2013657","journal-title":"Nat Rev Nephrol"},{"key":"149_CR10","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844\u20131859","journal-title":"Clin J Am Soc Nephrol"},{"key":"149_CR11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ndt\/gfi153","volume":"21","author":"RM Perkins","year":"2006","unstructured":"Perkins RM, Reynolds JC, Ahuja TS, Reid T, Agodoa LY, Bohen EM, Yuan CM, Abbott KC (2006) Thrombotic microangiopathy in United States long-term dialysis patients. Nephrol Dial Transplant 21:191\u2013196","journal-title":"Nephrol Dial Transplant"},{"key":"149_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molimm.2013.05.224","volume":"56","author":"EK Wong","year":"2013","unstructured":"Wong EK, Goodship TH, Kavanagh D (2013) Complement therapy in atypical haemolytic uraemic syndrome (aHUS). Mol Immunol 56:199\u2013212","journal-title":"Mol Immunol"},{"key":"149_CR13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/sim.5884","volume":"33","author":"EM Hade","year":"2014","unstructured":"Hade EM, Lu B (2014) Bias associated with using the estimated propensity score as a regression covariate. Stat Med 33:74\u201387","journal-title":"Stat Med"},{"key":"149_CR14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jclinepi.2004.10.016","volume":"58","author":"BR Shah","year":"2005","unstructured":"Shah BR, Laupacis A, Hux JE, Austin PC (2005) Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol 58:550\u2013559","journal-title":"J Clin Epidemiol"},{"key":"149_CR15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7326\/0003-4819-122-8-199504150-00002","volume":"122","author":"KH Shumak","year":"1995","unstructured":"Shumak KH, Rock GA, Nair RC (1995) Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group. Ann Intern Med 122:569\u2013572","journal-title":"Ann Intern Med"},{"key":"149_CR16","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/archinte.1994.00420090056006","volume":"154","author":"CP Hayward","year":"1994","unstructured":"Hayward CP, Sutton DM, Carter WH Jr, Campbell ED, Scott JG, Francombe WH, Shumak KH, Baker MA (1994) Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Arch Intern Med 154:982\u2013987","journal-title":"Arch Intern Med"},{"key":"149_CR17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1471-2369-13-164","volume":"13","author":"W Tang","year":"2012","unstructured":"Tang W, Mohandas J, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Clayton PA, Wiggins KJ, Bannister KM, Campbell SB, Johnson DW (2012) End-stage kidney disease due to haemolytic uraemic syndrome\u2014outcomes in 241 consecutive ANZDATA registry cases. BMC Nephrol 13:164\u2013175","journal-title":"BMC Nephrol"},{"key":"149_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/3-7643-7428-4_5","volume-title":"Complement and kidney disease","author":"M Noris","year":"2006","unstructured":"Noris M, Remuzzi G (2006) Non-Shiga toxin-associated hemolytic uremic syndrome. In: Zipfel P (ed) Complement and kidney disease. Birkh\u00e4user, Basel, pp 65\u201383"},{"key":"149_CR19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","volume":"60","author":"P Ruggenenti","year":"2001","unstructured":"Ruggenenti P, Noris M, Remuzzi G (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60:831\u2013846","journal-title":"Kidney Int"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-014-0149-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0149-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0149-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:58:23Z","timestamp":1777564703000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/28\/3\/361\/8372350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,10]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["149"],"URL":"https:\/\/doi.org\/10.1007\/s40620-014-0149-x","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,10]]}}}